Stock Evaluator: Ping An Biomedical Co., Ltd. (PASW)
Ping An Biomedical Co., Ltd. PASW
$0.13
-0.01
-8.49%
September 3, 2026 11:15:40 AM
EST
Volume: 869,922
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Consumer Discretionary | Distributors |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Ping An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finished garments; real estate property investment; and warehousing services. The company serves brand owners, textile manufacturers, apparel sourcing agents, and online fashion and garment retailers. It was formerly known as Majestic Ideal Holdings Ltd. and changed its name to Ping An Biomedical Co., Ltd. in September 2025. The company was founded in 2013 and is based in Cheung Sha Wan, Hong Kong. Ping An Biomedical Co., Ltd. operates as a subsidiary of Action Holdings Limited.
Financial Summary
| Share Statistics | PASW | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $16.8 | $51.3 | 9% |
|
| Shares Out (Mil) | 2.7 | 20.7 | 9% |
|
| Institutional Ownership | 2.4% | 25.2% | 3% |
|
| Float (Mil) | 97.5 | 6.4 | 60% |
|
| Beta | na | 0.83 | na |
|
| Avg Daily Volume (000s) | 35,461 | 87 | 99% |
|
| Price Change (52-week) |
(88.3%) | 55.6% | 5% |
|
| Growth | PASW | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | (10.2%) | 6.5% | 5% |
|
| Net Income (5yr) | (51.6%) | 2.1% | 6% |
|
| EPS (5yr) | (52.0%) | 2.3% | 3 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | 74.4% | 2.6% | 97% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | PASW | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $5 | $46 | 6% |
|
| Net Income (TTM) (Mil) | ($2) | $2 | 37% |
|
| EPS (TTM) | ($0.098) | $0.200 | 36% |
|
| Operating Cash Flow (TTM) (Mil) | ($1) | $3 | 31% |
|
| Net Cash Flow (TTM) (Mil) | $5 | $-0 | 52% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $3 | 0% |
|
| Enterprise Value (Q1) (Mil) | $23 | $94 | 12% |
|
| Valuation | PASW | Industry Median |
Percentile (All Stocks) |
|
| P/B | 0.44 | 1.69 | 7% |
|
| P/E | na | 13.0 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 2.4 | na |
|
| Ratios | PASW | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 2.8% | 24.6% | 5% |
|
| Net Margin | (37.6%) | 0.3% | 13% |
|
| ROA | (20.3%) | 1.5% | 20% |
|
| ROE | (67.6%) | 6.0% | 12% |
|
| Liabilities to Assets | 33.9% | 51.5% | 25% |
|
| F-Score | 3 | 3 | 18% |
|
Ping An Biomedical Co., Ltd. did not pass any screens on 9/2/2026.
